EIF4A1, a eukaryotic translation initiation factor, plays vital roles in protein translation initiation, participates in epithelial-to-mesenchymal transition (EMT) and is related to a poor prognosis in patients with gastric cancer [25]. This evidence concerns the gene EIF4A1 and gastric cancer.